VRS
KYNB

Virginia Retirement Systems’s Kyntra Bio KYNB Stock Holding History

Virginia Retirement Systems’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-400
Closed -$141 – 1147
2021
Q4 		$141 Buy
+400
New +$125K ﹤0.01% 1074
2020
Q3 		– Sell
-524
Closed -$531K – 1109
2020
Q2 		$531K Sell
524
-80
-13% -$74.3K 0.01% 772
2020
Q1 		$525K Hold
604
– – 0.01% 777
2019
Q4 		$648K Buy
+604
New +$617K 0.01% 859

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Virginia Retirement Systems's KYNB Position: Q1 2022 in Review

Virginia Retirement Systems sold out of Kyntra Bio (KYNB) in Q1 2022, closing a stake of 400 shares — an estimated $141 sold.

Virginia Retirement Systems first reported a position in KYNB in Q4 2019 and held it in 4 quarters. The position peaked at $648K in Q4 2019. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

  • Virginia Retirement Systems reported no remaining Kyntra Bio position as of Q1 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 400 Kyntra Bio shares in Q1 2022, an estimated $141.
  • Virginia Retirement Systems first reported a position in Kyntra Bio in Q4 2019 and held it in 4 quarters.
  • Virginia Retirement Systems's Kyntra Bio position peaked at $648K in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.